|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.8 CHF | -0.48% |
|
-2.39% | -6.42% |
| May. 27 | Roche renews diagnostic partnership with Hitachi | CF |
| May. 27 | Roche appoints Director of Corporate Business Development | CF |
BERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit.
Screening for HPV can help identify women who are at risk of developing cervical cancer at an earlier stage.
(Reporting by Rachel More, writing by Andrey Sychev)
| 1st Jan change | Capi. | |
|---|---|---|
| -6.42% | 203B | |
| +38.59% | 727B | |
| -7.89% | 354B | |
| +15.66% | 328B | |
| +0.24% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| +4.23% | 164B | |
| -1.70% | 164B | |
| -1.31% | 122B |
ROCHE HOLDING AG 
